Skip to main content
Book cover

Brain Edema pp 299–301Cite as

Thromboxane Synthetase Inhibition in Ischemic Brain Injury

  • Conference paper
  • 63 Accesses

Abstract

The purpose of this investigation was to study the effects of a selective thromboxane A2 (TXA2) synthetase inhibitor U.K. 38,485 (TSI) upon the evolution of cerebral infarction in the cat.

The work described in this paper was supported by a grant from the Cleveland Foundation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Awad I, Little Jr, Lucas F, et al. (1983) Modification of focal cerebral ischemia by prostacyclin and indomethacin. J Neurosurg 58:714–719

    Article  PubMed  CAS  Google Scholar 

  2. Cross PE, Dickinson RP, Parry MT, et al. (1981) 3-(1-Imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase. Agents Actions 11:274–280

    Article  PubMed  Google Scholar 

  3. Hossmann KA, Hossmann V (1977) Coagulopathy following experimental cerebral ischemia. Stroke 8:249–254

    Article  PubMed  CAS  Google Scholar 

  4. Jolly SR, Kane WT, Bailie MB, et al. (1983) Reduction of reperfusion injury after canine myocardial ischemia by superoxide dismutase plus catalase. Circulation 68 [Suppl 3]: 185 (abstract)

    Google Scholar 

  5. Ksiezycka E, Hastie R, Maroko RP, et al. (1983) Reduction in myocardial damage after experimental coronary artery occlusion by two techniques which deplete neutrophils. Circulation 68 [Suppl 3]: 185 (abstract)

    Google Scholar 

  6. Marcus AJ (1983) Recent progress in the role of platelets in occlusive vascular disease. Stroke 14:475–479

    Article  PubMed  CAS  Google Scholar 

  7. Randall MT, Parry MT, Hawkeswood E, et al. (1981) UK-37,248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Thromb Res 23:145–162

    Article  PubMed  CAS  Google Scholar 

  8. Rao PS, Cohen MV, Mueller HS (1983) Transcardiac production of thromboxane: prostacyclin and free radicals in early experimental myocardial ischemia. Circulation 68 [Suppl 3]: 185 (abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Moufarrij, N.A. et al. (1985). Thromboxane Synthetase Inhibition in Ischemic Brain Injury. In: Inaba, Y., Klatzo, I., Spatz, M. (eds) Brain Edema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70696-7_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70696-7_46

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70698-1

  • Online ISBN: 978-3-642-70696-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics